MedPath

What is the Optimal Training Model for Cervical Awareness?

Not Applicable
Completed
Conditions
HPV Infection
Cervical Dysplasia
Cervical Cancer
Registration Number
NCT06562595
Lead Sponsor
Izmir City Hospital
Brief Summary

Cervical cancer represents the fourth most prevalent malignant disease and the fourth leading cause of mortality among women on a global scale. Despite screening and preventive vaccination efforts, cervical cancer remains a significant cause of morbidity and mortality in low- and middle-income countries.

Detailed Description

A number of studies have been conducted with the aim of raising awareness about HPV and cervical cancer. However, there is currently no evidence-based consensus on the most effective method of education. The objective of this study is to identify the optimal training method by conducting a randomised controlled trial among healthcare professionals. The training methods under consideration are as follows: 1) Video-based training, 2) Classical lecture training, 3) Brochure, 4) Audio recording (Radio broadcast).

Prior to the commencement of the designated training methods, participants will be required to complete a web-based pre-test. Subsequent to this, the system will automatically assign each participant to a training intervention. Upon completion of the training programme, participants will be required to undertake a second test, the results of which will inform the selection of the most effective training method.

This study will be conducted separately in several distinct healthcare professional groups. Each randomized controlled trial will include 400 participants.

Planned groups include:

Public health nurses

Medical doctors

Medical interns

Midwives

The objective is to identify the most effective educational intervention for improving awareness of HPV and cervical cancer prevention within each group.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
400
Inclusion Criteria

Being over 18 and under 40

  • Female doctors, female nurses and female health technicians
  • Working in our hospital
  • Having sufficient mental capacity
  • Not having a visual or auditory disability
  • Volunteering to participate in the study
Exclusion Criteria
  • Under 18 and over 40
  • Not being a healthcare worker
  • Not having enough mental capacity
  • Having a visual or auditory disability
  • Patients who did not volunteer to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Test Score, Pre-TrainingAfter completion of the 25-item assessment tests (first and second test) and training, an average of 1 month.

Participants will first take a test where they will receive a maximum of 25 points and a minimum of 0 points. Then the participants will be automatically assigned to one of the 4 training models, then the trainings will be given and the same test will be applied to the participants again.

By looking at the second test and first test scores, it will be determined which training model increases the participant's score more. Thus, we will be able to understand which form of education increases HPV and cervical awareness in our society.

Test Score, Post-TrainingAfter completion of the 25-item assessment tests (first and second test) and training, an average of 1 month.

Participants will first take a test where they will receive a maximum of 25 points and a minimum of 0 points. Then the participants will be automatically assigned to one of the 4 training models, then the trainings will be given and the same test will be applied to the participants again.

By looking at the second test and first test scores, it will be determined which training model increases the participant's score more. Thus, we will be able to understand which form of education increases HPV and cervical awareness in our society.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Izmir City Hospital

🇹🇷

İzmir, Turkey

Izmir City Hospital
🇹🇷İzmir, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.